UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F COVER PAGE
OMB APPROVAL
OMB Number:3235-0006
Expires:July 31, 2015
Estimated average burden
hours per response:23.8
Report for the Calendar Year or Quarter Ended:
12-31-2024
Check here if Amendment: ☐ Amendment Number:
This Amendment (Check only one.):☐ is a restatement.
☐ adds new holdings entries.

Institutional Investment Manager Filing this Report:

Name:
BML Capital Management, LLC
Address:
65 E CEDAR - SUITE 2
ZIONSVILLE, IN 46077
Form 13F File Number:
028-22948

The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this form.


Person Signing this Report on Behalf of Reporting Manager:
Name:
Aryn Sands
Title:
Agent
Phone:
844-844-3453


Signature, Place, and Date of Signing:

Aryn Sands
                         [Signature]
Reno, NEVADA
                 [City, State]
02-06-2025
                           [Date]
                          

Report Type (Check only one.):

☒ 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) 

☐ 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) 

☐ 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).)


Form 13F Summary Page

Report Summary:

Number of Other Included Managers:
0
Form 13F Information table Entry Total:
25
Form 13F Information table Value Total:
160967144
          (thousands)

List of Other Included Managers:

Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
[If there are no entries in this list, state "NONE" and omit the column headings and list entries.]

  
NONE


UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number:3235-0006
Expires:July 31, 2015
Estimated average burden
hours per response:23.8
COLUMN 1COLUMN 2COLUMN 3COLUMN 4COLUMN 5COLUMN 6COLUMN 7COLUMN 8
VALUESHRS ORSH/PUT/INVESTMENTOTHERVOTING AUTHORITY
NAME OF ISSUERTITLE OF CLASSCUSIP(x$1000)PRN AMTPRNCALLDISCRETIONMANAGERSOLESHAREDNONE
AADI BIOSCIENCE INCCOM00032Q1046,625,5002,100,000SHSOLE 0 0 2,100,000
ACHILLES THERAPEUTICS PLCSPONSORED ADS00449L1024,674,0024,100,002SHSOLE 0 0 4,100,002
ACLARIS THERAPEUTICS INCCOM00461U10535,340,00014,250,000SHSOLE 0 0 14,250,000
ADVERUM BIOTECHNOLOGIES INCCOM NEW00773U20710,591,8592,268,064SHSOLE 0 0 2,268,064
ALLOVIR INCCOM01981810377,383184,246SHSOLE 0 0 184,246
AN2 THERAPEUTICS INCCOM0373261057,934,2165,749,432SHSOLE 0 0 5,749,432
ASTROTECH CORPCOM0464843091,481,155220,410SHSOLE 0 0 220,410
ATEA PHARMACEUTICALS INCCOM04683R10625,487,8457,608,312SHSOLE 0 0 7,608,312
ATHIRA PHARMA INCCOM04746L1041,628,6122,775,885SHSOLE 0 0 2,775,885
LISATA THERAPEUTICS INCCOM128058302848,314284,669SHSOLE 0 0 284,669
CONNECT BIOPHARMA HLDGS LTDADS2075231012,888,6602,093,232SHSOLE 0 0 2,093,232
ESSA PHARMA INCCOM NEW29668H7087,556,5674,221,546SHSOLE 0 0 4,221,546
HILLEVAX INCCOM43157M10242,97320,760SHSOLE 0 0 20,760
IKENA ONCOLOGY INCCOM45175G1085,880,8203,585,866SHSOLE 0 0 3,585,866
INSTIL BIO INCCOM NEW45783C2007,636,000400,000SHSOLE 0 0 400,000
ISHARES TR0-3 MNTH TREASRY46436E71826,083,200260,000SHSOLE 0 0 260,000
KEZAR LIFE SCIENCES INCCOM NEW49372L209327,04948,668SHSOLE 0 0 48,668
LENZ THERAPEUTICS INCCOM52635N103267,6549,271SHSOLE 0 0 9,271
MILESTONE PHARMACEUTICALS INCOM59935V1072,681,1751,136,091SHSOLE 0 0 1,136,091
NEXTCURE INCCOM65343E108210,896273,536SHSOLE 0 0 273,536
ORAMED PHARMACEUTICALS INCCOM NEW68403P2036,398,2552,643,907SHSOLE 0 0 2,643,907
PMV PHARMACEUTICALS INCCOM69353Y1035,234,6933,466,684SHSOLE 0 0 3,466,684
PALVELLA THERAPEUTICS INC NECOM697947109505,56042,130SHSOLE 0 0 42,130
VERRICA PHARMACEUTICALS INCCOM92511W108122,256174,651SHSOLE 0 0 174,651
VISTAGEN THERAPEUTICS INCCOM92840H400442,500150,000SHSOLE 0 0 150,000